The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 24, 2024
Filed:
Jan. 13, 2022
Applicant:
Biosceptre (Aust) Pty Ltd, North Ryde, AU;
Inventors:
Xiaojuan Gong, New South Wales, AU;
Minoo J Moghaddam, New South Wales, AU;
Julian Alexander Barden, New South Wales, AU;
Assignee:
BIOSCEPTRE (AUST) PTY LTD, North Ryde, AU;
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/69 (2017.01); A61K 9/127 (2006.01); A61K 9/16 (2006.01); A61K 31/7068 (2006.01); A61K 47/54 (2017.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); C07K 16/18 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6913 (2017.08); A61K 9/127 (2013.01); A61K 9/1271 (2013.01); A61K 9/1617 (2013.01); A61K 31/7068 (2013.01); A61K 47/542 (2017.08); A61K 47/545 (2017.08); A61K 47/6849 (2017.08); A61P 35/00 (2018.01); C07K 16/18 (2013.01); C07K 16/28 (2013.01); C07K 16/30 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); C07K 2317/565 (2013.01);
Abstract
The invention relates to cytotoxic particles for cancer therapy including a core and a plurality of variable domains arranged on the core for binding to P2X7 receptors on a cancer cell.